Maple-Brown Abbott Australian Share Fund – Wholesale

The Fund is invested in companies listed (or expected to be listed) on an Australian securities exchange and is actively managed.

Our value-based investment philosophy underlies our approach to stock selection, driven by our bottom-up research process designed to maximise the opportunities to deliver income and long-term capital growth to our clients. We use several valuation screens to rank our investment universe and generate stock ideas. Our experienced team then undertakes detailed quantitative and qualitative analysis to identify companies that are trading at a discount to our assessment of their underlying value.

The Fund provides exposure to a diversified portfolio of our highest conviction opportunities which we expect to deliver strong risk-adjusted returns over the long-term. We aim to invest across a broad universe of Australian companies and will typically hold 25–40 stocks.

Investment objective

The Fund aims to outperform the S&P/ASX 200 Total Return Index, after fees, over a four-year period.

Fund facts
Inception date31/05/1998Distribution frequencyQuarterly
BenchmarkS&P/ASX 200 Total Return IndexMinimum initial application$ 100,000
APIR codeADV0046AUManagement fees and costs %*^0.80
Pricing frequency & cut-offDaily/2pm Sydney time on a Business DayBuy/Sell spread %^0.19/0.19

*Management fees and costs for the Fund are made up of the management fee, indirect costs (if any) and estimated recoverable expenses.
^Additional fees and costs may also apply in relation to an investment in the Fund. For a full description of the fees and costs refer to the Product Disclosure Statement and Additional Information Booklet for the Fund.

Portfolio Managers

A team of experienced and dedicated investment professionals.

Garth Rossler | Chief Investment Officer | Maple-Brown Abbott
Garth Rossler
Chief Investment Officer
Dougal Maple-Brown | Head of Australian Value Equities | Maple-Brown Abbott
Dougal Maple-Brown
Head of Australian Value Equities

Fund performance^

as at 30/06/2024

1 mth %3 mths %1 yr % p.a.3 yrs % p.a.4 yrs % p.a.5 yrs % p.a.Since inception % p.a.*

^Past performance is not a reliable indicator of future performance. No warranty can be given for future performance. Returns are volatile and may fluctuate quickly and significantly. Performance figures are calculated using withdrawal values and assume that income is reinvested. Annual management fees and expenses have been taken into account, however no allowance has been made for tax or any rebates that may be given. Source: Maple-Brown Abbott and S&P
*Inception date is 1 June 1998.

Unit price

as at 11/07/2024

Download unit price history
Application priceNet asset valueRedemption price
$ 0.9551$ 0.9533$ 0.9515
DateCents per unitReinvestment priceDiv 12-H summaryTaxable component summary
28/06/20242.9966 ¢$ 0.9461

Forms and fund information

Fund ratings 

Zenith recommended logo
Lonsec Research Recommended logo

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned ADV0046AU June 2023) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.

The Lonsec rating issued 09/2023 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit for ratings information and to access the full report. © 2023 Lonsec. All rights reserved.

Interested in investing with us?